Jci_page_head_homepage_01 Jci_page_head_homepage_02
Juscilene S. Menezes, Peter van den Elzen, Jordan Thornes, Donald Huffman, Nathalie M. Droin, Emanual Maverakis, Eli E. Sercarz
Published in Volume 117, Issue 8
J Clin Invest. 2007; 117(8):2176–2185 doi:10.1172/JCI28277
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 4
CD4+ BV8S2/BJ2S7-DAGGGY clonotypic T cells induce EAE.

(A) Cells from mice immunized with Ac1–9 8 days earlier were stimulated in vitro with the peptide and IL-12; sorted into CD4+, CD4+BV8.2+, and CD4+BV8.2 populations; and adoptively transferred into naive mice. (B) The BV8.2+ T cell clone bearing the DAGGGY motif in the CDR3 region and the Ac1–9–specific T cell line depleted of BV8.2+ T cells were stimulated in vitro with the peptide and IL-12, washed, and adoptively transferred into naive mice. The numerical range of cells transferred was adjusted for different populations as described in Methods. Mice were monitored daily for clinical signs of EAE.